U.S. Metals and Mining Stock News

Earlier in February 2026, ACADIA Pharmaceuticals received a formal negative opinion from the EMA’s CHMP on its marketing application for trofinetide in Rett syndrome, while also appointing biopharma finance executive Jonathan M. Poole to its Board and preparing a leadership presentation at the Longwood Healthcare Leaders Miami conference. This mix of regulatory setback in Europe and added financial expertise on the Board highlights a pivotal moment for ACADIA’s rare disease and CNS growth...

VNET Group (NasdaqGS:VNET) just reported FY 2025 third quarter revenue of C¥2.6b with a basic EPS loss of C¥1.14, while trailing twelve month revenue stood at C¥9.5b alongside a basic EPS loss of C¥2.17. The company has seen quarterly revenue move from C¥2.0b in Q2 2024 to C¥2.1b in Q3 2024, C¥2.2b in Q4 2024 and Q1 2025, C¥2.4b in Q2 2025 and now C¥2.6b in Q3 2025, with EPS swinging between a profit of C¥1.19 in Q3 2024 and losses including C¥0.89 in Q1 2025 and C¥1.14 in the latest quarter...

Science Applications International (SAIC) has just posted fresh FY 2026 numbers, with third quarter revenue of US$1,866 million and basic EPS of US$1.70, alongside trailing 12 month revenue of US$7.4 billion and EPS of US$7.86. Over recent quarters the company has seen revenue range from US$1,769 million to US$1,877 million and quarterly EPS move between US$1.43 and US$2.72. This gives investors a clearer view of how the current run rate feeds into those trailing figures. With trailing net...

If you are wondering whether AES at around US$14.20 is now priced attractively or still has room to fall further, this article breaks down what the current share price implies about value. The stock has had a mixed run, with a 0.1% move over the last 7 days, a 12.8% decline over the past month, a 4.2% decline year to date, a 15.0% gain over the past year, and deeper 3 year and 5 year declines of 28.1% and 33.9% respectively. These moves sit against a backdrop of ongoing attention on...

Wondering if Capital Southwest at around US$21.38 is offering fair value or a possible mispricing? This article walks through the key numbers so you can judge for yourself. The stock has seen a 3.1% decline over the past 7 days and 6.3% over the last 30 days, despite a 10.2% return over 1 year and 76.8% over 3 years. Recent coverage has focused on Capital Southwest's role as a business development company and how its market position and portfolio decisions feed into investor expectations...

The RealReal recently expanded its leadership and governance team, adding Fanatics Commerce COO Jennifer McKeehan to its board while appointing Tiffany Stevenson as Chief People Officer and Tom Hanrahan as Chief Revenue Officer, and also saw Niki Leondakis step down from the board as of March 6, 2026. At the same time, luxury designer Alejandra Alonso Rojas chose The RealReal as a partner to extend the life of her certified sustainable garments, underscoring the platform’s role in...

Dollar Tree (DLTR) has just posted its latest FY 2026 numbers, with Q3 revenue of US$4.8b and basic EPS of US$1.20 setting the tone for the year to date. The company has seen quarterly revenue move from US$4.1b in Q2 FY 2025 to US$4.6b in Q1 FY 2026 and US$4.8b in Q3 FY 2026, while basic EPS has ranged from US$0.66 to US$1.47 over the same stretch, giving you a clear read on how sales and earnings are tracking into the back half of the year. With trailing 12 month net income described as high...

In March 2026, Stoke Therapeutics and Biogen reported New England Journal of Medicine data showing that investigational antisense therapy zorevunersen produced substantial, durable seizure reductions and multi-year cognitive and behavioral improvements in children and adolescents with Dravet syndrome on top of standard anti-seizure medicines, with an overall safety profile the companies describe as generally well tolerated. The publication is important because it presents multi-year...

Recently, NewMarket Corporation has come under pressure as its core petroleum additives business faces structural oversupply, with global capacity additions outstripping demand and intensifying competition from Chinese exporters. An additional concern for investors is that bearish research has highlighted how NewMarket’s heavy reliance on this challenged segment could weigh on overall profitability despite past diversification efforts. Against this backdrop, we’ll explore how persistent...

VinFast Auto (NasdaqGS:VFS) has just posted another loss making quarter, with Q3 FY 2025 revenue of about ₫18.1 trillion and basic EPS of a loss of ₫10,238.74, set against a trailing twelve month revenue base of roughly ₫67.5 trillion and a cumulative loss of about ₫92.5 trillion. Over recent periods the company has seen quarterly revenue move from about ₫8.7 trillion in Q2 FY 2024 to ₫12.3 trillion in Q3 FY 2024, ₫16.3 trillion in Q1 FY 2025 and now ₫18.1 trillion in Q3 FY 2025, while...

Latest FY 2025 Earnings Snapshot WaterBridge Infrastructure (WBI) just posted its FY 2025 numbers with third quarter revenue of US$123.25 million and a basic EPS loss of US$0.02, while net income excluding extra items was a loss of US$0.67 million. The company has seen revenue move from US$89.80 million in the third quarter of 2024 to US$123.25 million in the same period of 2025. The trailing twelve month revenue figure in the dataset stands at US$733.30 million with a net loss of US$91.25...

CoreCivic recently obtained a Special Use Permit for its Midwest Regional Reception Center in Leavenworth, Kansas, allowing the previously idled facility to resume operations and begin accepting detainees on a phased basis. This regulatory approval effectively brings an additional revenue-generating asset back online, with phased intake potentially enhancing utilization and supporting CoreCivic’s broader detention services footprint. We’ll now examine how reactivating the Midwest Regional...

Trupanion (TRUP) shares are in focus after the Human Animal Bond Research Institute announced a new partnership with the pet insurer, centering on research and support for service dogs and the broader human animal bond. See our latest analysis for Trupanion. Despite the HABRI partnership highlighting Trupanion's role in supporting the human animal bond, the stock has faced selling pressure, with a 90 day share price return of 32.03% decline and a 1 year total shareholder return of 31.47%...

In recent days, Corebridge Financial has faced sector-wide pressure as concerns about private credit stability, tighter lending to private credit providers, and fund redemption limits prompted investors to reassess risk across financial companies. At the same time, Corebridge Financial increased its dividend by 4% for shareholders of record as of March 17, 2026, signaling management’s emphasis on returning capital despite heightened market scrutiny of its private credit exposure and cash...

Earlier this month, The Toro Company reported first-quarter fiscal 2026 results showing sales of US$1,036.3 million and net income of US$67.9 million, and management raised full-year 2026 net sales growth guidance to a range of 3% to 6.5%. Management attributed the stronger performance and confidence in higher guidance to robust demand for snow and ice products, contributions from recent acquisitions, and progress on cost-saving initiatives such as the AMP productivity program. Next, we’ll...

In March 2026, Par Pacific Holdings attracted increased attention as Barclays PLC raised its stake by almost one-quarter, while multiple brokerage firms maintained an “Outperform” consensus rating on the company. This combination of higher institutional ownership and supportive analyst views highlights growing institutional engagement with Par Pacific’s refining and fuel distribution footprint in Hawaii and the Rocky Mountain region. We’ll now explore how rising institutional ownership,...

Oruka Therapeutics, Inc. recently reported fourth-quarter 2025 results showing a net loss of US$29.58 million and a full-year 2025 net loss of US$105.43 million, alongside narrowing quarterly loss per share from continuing operations to US$0.45. On the same day, the company filed a US$115.44 million shelf registration for 3,354,715 ordinary shares tied to an ESOP-related offering, highlighting its focus on funding flexibility while advancing mid-stage trials for ORKA-002 in psoriasis and...

In March 2026, Tetra Tech, Inc. announced that Naval Facilities Engineering Systems Command Southeast selected its joint venture with Mason & Hanger for a US$99 million, five-year single-award task order contract to deliver multidiscipline architect-engineer services supporting resilient U.S. Navy infrastructure across the NAVFAC Southeast area of operations. This win deepens Tetra Tech’s role in defense-related infrastructure, provides multiyear revenue visibility, and could enhance its...

Earlier in March 2026, Otis Worldwide introduced its Viva solutions, a suite of elevator upgrades and features designed to improve safety, accessibility and comfort for aging populations, while also coming standard on its Gen3 and Gen360 systems across major global markets. The focus on intergenerational mobility and retrofit-friendly upgrades positions Viva as a way for building owners to extend asset life, meet evolving accessibility standards and enhance passenger experience without full...

Event context and recent stock moves Hayward Holdings (HAYW) has been drawing attention after a period of weaker share performance, with the stock showing a 15% decline over the past month and about 11% over the past 3 months. See our latest analysis for Hayward Holdings. Beyond the recent pullback, Hayward’s 1 day, 7 day and 30 day share price returns are all in negative territory. However, the 3 year total shareholder return of about 27% points to a more constructive longer term picture. If...

RB Global (RBA) has put a new US$500 million share repurchase plan on the table, targeting up to 10,000,000 shares. The move immediately shifts attention to capital allocation and shareholder returns. See our latest analysis for RB Global. The buyback news comes after a softer period for the shares, with a 7 day share price return of 6.72% and a 90 day share price return of 5.29%. In contrast, the 3 year total shareholder return of 99.05% and 5 year total shareholder return of 91.35% indicate...

Quaker Chemical (KWR) has been drawing attention after a period of weaker share performance, with the stock down about 34% over the past month and 14% over the past 3 months. See our latest analysis for Quaker Chemical. Looking beyond the recent slump, Quaker Chemical’s 30-day share price return of 33.95% and year to date share price return of 14.76% contrast with a 1-year total shareholder return of 4.99% and a 5-year total shareholder return of 48.90%. This suggests that shorter term...

In early March 2026, Radware launched its Web DDoS Protection for Encrypted Traffic as a cloud-based service that blocks sophisticated layer 7 DDoS attacks without requiring SSL certificate sharing or traffic decryption, addressing privacy, regulatory, and key management concerns. The company positions this as a first-of-its-kind cloud offering that uses AI-driven behavioral analysis to protect the rising volume of encrypted web traffic across cloud, on-premises, hybrid, and...

Tango Therapeutics, Inc. has reported fourth-quarter 2025 net loss of US$38.75 million and a full-year 2025 net loss of US$101.59 million, alongside full-year revenue of US$62.38 million, while also filing a US$95.67 million common stock shelf registration related to its employee stock ownership plan. Erasca, Inc.’s recent clinical trial collaboration and supply agreement with Tango to combine ERAS-0015 and vopimetostat in MTAP-deleted pancreatic and lung cancers adds an additional layer of...